{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Utilization of Optimal Medical Therapy in Chronic Limb Threatening Ischemia: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was conducted at the patient level"
      },
      "Participants": {
        "score": 2,
        "evidence": "The trial enrolled patients diagnosed with CLTI across multiple centers. Eligibility criteria included confirmed CLTI."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the utilization of guideline-based optimal medical therapy (OMT) at the time of trial enrollment."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the proportion of patients meeting OMT criteria at baseline."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted at the patient level, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 1830 patients were randomised."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Adherence to OMT was modest, with only 25% meeting all four criteria, 38% meeting three, 24% meeting two, 11% meeting one, and 2% meeting none."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: NIH-sponsored."
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}